KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹170 Cr | ₹152 Cr | ₹126 Cr | ₹139 Cr | ₹78 Cr |
What is the latest Total Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹170 Cr |
| Mar2024 | ₹152 Cr |
| Mar2023 | ₹126 Cr |
| Mar2022 | ₹139 Cr |
| Mar2021 | ₹78 Cr |
How is Total Current Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹170 Cr | 11.63 | |
| Mar2024 | ₹152 Cr | 20.57 | |
| Mar2023 | ₹126 Cr | -9.71 | |
| Mar2022 | ₹139 Cr | 78.16 | |
| Mar2021 | ₹78 Cr | - | |
Compare Total Current Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,522.0 Cr | -6.4% | 2.7% | 107.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,555.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,889.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,073.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | -6.4% |
2.7% |
107.9% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses